Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2021-05-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebellar RTMS in Patients with Multiple Sclerosis
NCT06265922
Cerebellar Non-invasive Stimulation in Ataxias
NCT03213106
Detecting the Rest Tremor Associated With Parkinson's Disease Using Analysis of the Muscle Contractions Rhythmicity
NCT05998486
Cerebellar rTMS for Essential Tremor
NCT02704793
Transcranial Magnetic Stimulation to Study Imagination of Movement
NCT00046215
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Spectral analysis and the correlation of the average signal spectra will be computed. Moreover, categorization based on the tremor component according to the maximum likelihood estimation will be done.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with multiple sclerosis
MS patients will be chosen by an independent neurologist.
Examination of tremor and upper hand functions
Participants will be only examined. They will not undergo any intervention.
Healthy volunteers
Healthy controls will be paired by age and sex with MS patients.
Examination of tremor and upper hand functions
Participants will be only examined. They will not undergo any intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Examination of tremor and upper hand functions
Participants will be only examined. They will not undergo any intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Definite diagnosis of MS
* prevailed motor deficit of upper extremities, but without visible tremor
* stable clinical status in the preceding 3 months
* Expanded Disability Status Scale score (EDSS) ≥ 2 ≤ 7.5, and
* no corticosteroid therapy in the preceding month
Group 2:
* Healthy volunteers in the age of 20-70 years will be employed
* There will be defined as persons without any neurological disease diagnose at the time of the measurement.
Exclusion Criteria
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles University, Czech Republic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kamila Řasová
associate professor PhDr. Kamila Řasová, Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kamila Řasová, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Third Faculty of Mecicine, Charles Univerzity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of neurology
Prague, , Czechia
Kamila Řasová
Prague, , Czechia
Deparment of revmatology and rehabilitation
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK-VP/23/0/2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.